| P2093 | author name string | Li Wei | |
| | Jun Yu | |
| | Yong Wu | |
| | Ning Pu | |
| | Wenhui Lou | |
| | Shanshan Gao | |
| | Wenchuan Wu | |
| | Lingdi Yin | |
| | Shimpei Maeda | |
| | Gao Liu | |
| | Haijie Hu | |
| | Yayun Zhu | |
| | Qiangda Chen | |
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| | Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 |
| | The pancreas cancer microenvironment | Q27026705 |
| | KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma | Q27853365 |
| | Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 |
| | Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 |
| | STRING v10: protein-protein interaction networks, integrated over the tree of life | Q29615545 |
| | Influence of tumour micro-environment heterogeneity on therapeutic response | Q29617534 |
| | limma powers differential expression analyses for RNA-sequencing and microarray studies | Q29617988 |
| | Inferring tumour purity and stromal and immune cell admixture from expression data | Q30674996 |
| | Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer | Q33728086 |
| | Endocannabinoids and immune regulation | Q34607419 |
| | Whole genomes redefine the mutational landscape of pancreatic cancer | Q35911034 |
| | The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma | Q35967008 |
| | A Molecular Portrait of High-Grade Ductal Carcinoma In Situ | Q36622366 |
| | Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells | Q37308216 |
| | Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression | Q37490376 |
| | Role of immune cells in pancreatic cancer from bench to clinical application: An updated review | Q37606102 |
| | Stromal cues regulate the pancreatic cancer epigenome and metabolome | Q37626183 |
| | CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway. | Q37708853 |
| | Tumor microenvironment and breast cancer progression: a complex scenario | Q37984168 |
| | Immunodeficiency in Pancreatic Adenocarcinoma with Diabetes Revealed by Comparative Genomics | Q38690307 |
| | Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component | Q38690817 |
| | Computational genomics tools for dissecting tumour-immune cell interactions | Q38885361 |
| | Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer | Q38889500 |
| | Low frequency of KRAS mutation in pancreatic ductal adenocarcinomas in Korean patients and its prognostic value | Q38928164 |
| | Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature | Q39093926 |
| | Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer. | Q39831543 |
| | Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway. | Q40133231 |
| | Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma. | Q40151513 |
| | Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism | Q42052824 |
| | Classifying the evolutionary and ecological features of neoplasms | Q45067426 |
| | Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome | Q45346380 |
| | Expression of macrophage-derived chemokine (MDC)/CCL22 in human lung cancer | Q47644849 |
| | Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression | Q47673750 |
| | Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma | Q47950548 |
| | Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies. | Q47959293 |
| | High immune cell score predicts improved survival in pancreatic cancer | Q48504662 |
| | Genomic hallmarks of localized, non-indolent prostate cancer. | Q50211176 |
| | TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. | Q51768874 |
| | Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. | Q51798642 |
| | Understanding the tumor immune microenvironment (TIME) for effective therapy. | Q52311744 |
| | Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset. | Q53828186 |
| | Mining TCGA database for genes of prognostic value in glioblastoma microenvironment. | Q54195728 |
| | Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression. | Q55420715 |
| | CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer | Q57788032 |
| | Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma | Q60609560 |
| | C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer | Q89003018 |
| | Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy | Q89352753 |
| | Cancer statistics, 2019 | Q90941571 |
| | Neutralizing TGF-β promotes anti-tumor immunity of dendritic cells against pancreatic cancer by regulating T lymphocytes | Q91091017 |
| | Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer | Q91321968 |
| | Immune cell score in pancreatic cancer-comparison of hotspot and whole-section techniques | Q92182866 |
| | Cell-intrinsic PD-1 promotes proliferation in pancreatic cancer by targeting CYR61/CTGF via the hippo pathway | Q92986415 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| | limma | Q112236343 |
| P433 | issue | 22 | |
| P921 | main subject | invasive ductal carcinoma | Q1671685 |
| | pancreatic ductal carcinoma | Q8263002 |
| | pancreatic ductal adenocarcinoma | Q18555956 |
| P304 | page(s) | 645 | |
| P577 | publication date | 2019-11-01 | |
| P1433 | published in | Annals of Translational Medicine | Q26842362 |
| P1476 | title | Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment | |
| P478 | volume | 7 | |